Q1 EPS Estimates for Avanos Medical Reduced by Analyst

Avanos Medical, Inc. (NYSE:AVNS) – Equities researchers at Zacks Research cut their Q1 2025 earnings estimates for shares of Avanos Medical in a research note issued to investors on Wednesday, March 19th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.19 per share for the quarter, down from their previous estimate of $0.29. The consensus estimate for Avanos Medical’s current full-year earnings is $1.32 per share. Zacks Research also issued estimates for Avanos Medical’s Q2 2025 earnings at $0.29 EPS, Q4 2025 earnings at $0.42 EPS, Q1 2026 earnings at $0.31 EPS, Q3 2026 earnings at $0.39 EPS, Q4 2026 earnings at $0.49 EPS and FY2027 earnings at $1.43 EPS.

Avanos Medical (NYSE:AVNS) last issued its earnings results on Wednesday, February 26th. The company reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. Avanos Medical had a net margin of 2.30% and a return on equity of 4.70%. The company had revenue of $179.60 million during the quarter, compared to analysts’ expectations of $177.23 million.

Separately, StockNews.com raised shares of Avanos Medical from a “hold” rating to a “buy” rating in a research report on Wednesday.

Avanos Medical Stock Down 0.6 %

AVNS stock opened at $14.67 on Friday. The company has a 50 day moving average price of $15.83 and a two-hundred day moving average price of $18.72. Avanos Medical has a one year low of $14.25 and a one year high of $25.36. The stock has a market capitalization of $675.05 million, a P/E ratio of 43.16 and a beta of 1.17. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.46 and a current ratio of 2.22.

Hedge Funds Weigh In On Avanos Medical

A number of large investors have recently made changes to their positions in the business. Illinois Municipal Retirement Fund lifted its stake in shares of Avanos Medical by 3.1% in the 4th quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company’s stock valued at $402,000 after purchasing an additional 748 shares during the last quarter. Comerica Bank grew its holdings in shares of Avanos Medical by 3.4% during the 4th quarter. Comerica Bank now owns 22,903 shares of the company’s stock worth $365,000 after purchasing an additional 755 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Avanos Medical by 3.6% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,834 shares of the company’s stock valued at $411,000 after buying an additional 901 shares in the last quarter. KBC Group NV lifted its stake in Avanos Medical by 63.0% during the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares during the period. Finally, EP Wealth Advisors LLC boosted its stake in Avanos Medical by 14.6% in the 4th quarter. EP Wealth Advisors LLC now owns 10,108 shares of the company’s stock valued at $161,000 after buying an additional 1,289 shares in the last quarter. Institutional investors and hedge funds own 95.17% of the company’s stock.

Insiders Place Their Bets

In other Avanos Medical news, SVP Kerr Holbrook sold 7,000 shares of the company’s stock in a transaction dated Thursday, March 6th. The shares were sold at an average price of $15.25, for a total value of $106,750.00. Following the completion of the sale, the senior vice president now directly owns 82,047 shares of the company’s stock, valued at approximately $1,251,216.75. This represents a 7.86 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.94% of the stock is owned by corporate insiders.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.